BIAF · Categories · Form 4

BIAF - SEC Form 4 insider transactions

bioAffinity Technologies Inc. (BIAF) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for BIAF

• 510d
  Chief Operating Officer Reveles Xavier Trinidad was granted 21,604 shares, increasing direct ownership by 106% to 41,943 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 510d
  Secretary, EVP, Gen. Counsel Zannes Timothy P was granted 8,641 shares, increasing direct ownership by 19% to 54,765 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 510d
  President & CEO Zannes Maria was granted 37,037 shares, increasing direct ownership by 15% to 280,359 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 510d
  Executive Chairman Girgenti Steven was granted 14,814 shares, increasing direct ownership by 1% to 1,080,062 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 510d
  VP and CFO Edwards James Michael was granted 6,172 shares, increasing direct ownership by 5% to 120,128 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 580d
  VP and CFO Edwards James Michael was granted 100,000 shares, increasing direct ownership by 717% to 113,956 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 706d
  Director Diamond Stuart was granted 33,784 shares, increasing direct ownership by 52% to 99,088 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 706d
  Executive Chairman Girgenti Steven was granted 33,784 shares, increasing direct ownership by 3% to 1,065,248 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 706d
  Director Rubin Gary D was granted 33,784 shares, increasing direct ownership by 30% to 146,597 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 706d
  Director Anderson Robert A. was granted 33,784 shares, increasing direct ownership by 26% to 163,936 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 706d
  Director Knight Peter S was granted 33,784 shares, increasing direct ownership by 40% to 117,455 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 706d
  Director Platt Jamie was granted 33,784 shares, increasing direct ownership by 161% to 54,748 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 706d
  Director Joyce Roby was granted 33,784 shares, increasing direct ownership by 103% to 66,615 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 706d
  President & CEO Zannes Maria was granted 33,784 shares, increasing direct ownership by 16% to 243,322 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 724d
  Director Rubin Gary D was granted 8,296 shares, increasing direct ownership by 8% to 112,813 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 724d
  Director Diamond Stuart was granted 8,296 shares, increasing direct ownership by 15% to 65,304 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 724d
  President & CEO Zannes Maria was granted 8,296 shares, increasing direct ownership by 4% to 209,538 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 724d
  Director Joyce Roby was granted 8,296 shares, increasing direct ownership by 34% to 32,831 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 724d
  Executive Chairman Girgenti Steven was granted 8,296 shares, increasing direct ownership by 0.81% to 1,031,464 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 724d
  Director Anderson Robert A. was granted 8,296 shares, increasing direct ownership by 7% to 130,152 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 724d
  Director Knight Peter S was granted 8,296 shares, increasing direct ownership by 11% to 83,671 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 724d
  Director Platt Jamie was granted 8,296 shares, increasing direct ownership by 65% to 20,964 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 776d
  Zannes Timothy P covered exercise/tax liability with 29,031 shares and exercised 64,848 shares at a strike of $1.16, increasing direct ownership by 348% to 46,124 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 776d
  Girgenti Steven exercised 64,848 shares at a strike of $1.16 and covered exercise/tax liability with 33,438 shares, increasing direct ownership by 3% to 1,023,168 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 776d
  Zannes Maria exercised 64,848 shares at a strike of $1.16 and covered exercise/tax liability with 28,264 shares, increasing direct ownership by 22% to 201,242 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 801d
  Girgenti Steven was granted 39,474 shares, increasing direct ownership by 4% to 991,758 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 801d
  Anderson Robert A. exercised 64,848 shares at a strike of $1.16, increasing direct ownership by 114% to 121,856 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 857d
  Zannes Timothy P was granted 6,688 shares, increasing direct ownership by 185% to 10,307 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 857d
  Zannes Maria was granted 23,885 shares, increasing direct ownership by 17% to 164,658 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 857d
  Reveles Xavier Trinidad was granted 16,720 shares, increasing direct ownership by 462% to 20,339 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 857d
  Rebel Vivienne I was granted 31,847 shares, increasing direct ownership by 221% to 46,228 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 857d
  Girgenti Steven was granted 11,943 shares, increasing direct ownership by 1% to 952,284 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 857d
  Dougherty Michael Philip was granted 31,847 shares, increasing direct ownership by 61% to 84,203 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 866d
  Girgenti Steven was granted 24,535 shares, increasing direct ownership by 3% to 940,341 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 866d
  Rubin Gary D was granted 24,535 shares, increasing direct ownership by 31% to 104,517 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 866d
  Knight Peter S was granted 24,535 shares, increasing direct ownership by 48% to 75,375 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 866d
  Zannes Maria was granted 24,535 shares, increasing direct ownership by 21% to 140,773 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 866d
  Diamond Stuart was granted 24,535 shares, increasing direct ownership by 76% to 57,008 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 866d
  Meghji Mohsin Y was granted 11,867 shares, increasing direct ownership by 12% to 109,737 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 866d
  Anderson Robert A. was granted 24,535 shares, increasing direct ownership by 76% to 57,008 units (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 866d
  Platt Jamie was granted 12,668 shares (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 866d
  Joyce Roby was granted 24,535 shares (SEC Form 4)

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 1033d
  SEC Form 4: Girgenti Steven was granted 54,707 shares, increasing direct ownership by 6% to 915,806 units

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 1069d
  SEC Form 4 filed by Meghji Mohsin Y

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 1069d
  SEC Form 4 filed by Anderson Robert A.

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 1069d
  SEC Form 4 filed by Diamond Stuart

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 1069d
  SEC Form 4 filed by Knight Peter S

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 1069d
  SEC Form 4 filed by Dougherty Michael Philip

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 1069d
  SEC Form 4 filed by Zannes Maria

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 1069d
  SEC Form 4 filed by Rubin Gary D

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 1069d
  SEC Form 4 filed by Girgenti Steven

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 1189d
  SEC Form 4: Perlmutter Nathan M converted options into 161,820 shares, increasing direct ownership by 97% to 327,909 units

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)
• 1189d
  SEC Form 4: Meghji Mohsin Y converted options into 40,907 shares, increasing direct ownership by 143% to 69,478 units

  4 - bioAffinity Technologies, Inc. (0001712762) (Issuer)

Other BIAF categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends